Fulton Bank’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.15M Sell
20,807
-659
-3% -$58.8K 0.07% 203
2026
Q1
$1.54M Sell
21,466
-885
-4% -$68.2K 0.05% 238
2025
Q4
$1.77M Sell
22,351
-2,485
-10% -$196K 0.06% 205
2025
Q3
$1.87M Sell
24,836
-10,539
-30% -$722K 0.07% 195
2025
Q2
$2.44M Sell
35,375
-2,428
-6% -$159K 0.09% 156
2025
Q1
$2.56M Buy
37,803
+4,613
+14% +$276K 0.1% 143
2024
Q4
$1.49M Sell
33,190
-4,923
-13% -$276K 0.06% 218
2024
Q3
$2.4M Sell
38,113
-12,828
-25% -$748K 0.09% 161
2024
Q2
$3.01M Buy
50,941
+3,882
+8% +$243K 0.12% 124
2024
Q1
$3.75M Sell
47,059
-1,569
-3% -$120K 0.15% 106
2023
Q4
$3.84M Sell
48,628
-4,455
-8% -$317K 0.17% 97
2023
Q3
$3.71M Sell
53,083
-3,832
-7% -$272K 0.18% 93
2023
Q2
$3.93M Buy
56,915
+7,191
+14% +$512K 0.19% 92
2023
Q1
$3.69M Sell
49,724
-578
-1% -$48.5K 0.19% 92
2022
Q4
$4.69M Buy
50,302
+3,466
+7% +$334K 0.26% 67
2022
Q3
$4.47M Buy
46,836
+1,948
+4% +$193K 0.27% 64
2022
Q2
$4.16M Buy
44,888
+266
+0.6% +$26K 0.23% 74
2022
Q1
$4.52M Buy
44,622
+2,394
+6% +$251K 0.21% 80
2021
Q4
$4.36M Buy
42,228
+5,167
+14% +$477K 0.19% 88
2021
Q3
$3.15M Buy
37,061
+7,632
+26% +$639K 0.15% 107
2021
Q2
$2.46M Buy
29,429
+1,718
+6% +$141K 0.11% 127
2021
Q1
$2.08M Buy
27,711
+126
+0.5% +$9.18K 0.11% 141
2020
Q4
$1.88M Buy
27,585
+4,278
+18% +$278K 0.1% 151
2020
Q3
$1.36M Sell
23,307
-3,695
-14% -$230K 0.08% 164
2020
Q2
$1.75M Sell
27,002
-11,238
-29% -$708K 0.12% 135
2020
Q1
$2.27M Sell
38,240
-5,546
-13% -$370K 0.18% 104
2019
Q4
$3.25M Buy
43,786
+1,870
+4% +$131K 0.2% 94
2019
Q3
$2.64M Buy
41,916
+30
+0.1% +$1.78K 0.18% 111
2019
Q2
$2.28M Buy
41,886
+5,097
+14% +$274K 0.15% 119
2019
Q1
$1.99M Sell
36,789
-761
-2% -$47K 0.14% 126
2018
Q4
$2.46M Buy
37,550
+2,130
+6% +$159K 0.2% 103
2018
Q3
$2.79M Buy
35,420
+160
+0.5% +$11.4K 0.18% 99
2018
Q2
$2.27M Sell
35,260
-124
-0.4% -$8.17K 0.16% 117
2018
Q1
$2.2M Buy
35,384
+2,894
+9% +$208K 0.15% 113
2017
Q4
$2.36M Buy
32,490
+1,077
+3% +$78.3K 0.17% 110
2017
Q3
$2.56M Buy
31,413
+1,717
+6% +$136K 0.19% 95
2017
Q2
$2.39M Sell
29,696
-2,240
-7% -$177K 0.19% 97
2017
Q1
$2.51M Buy
31,936
+14,432
+82% +$1.15M 0.21% 92
2016
Q4
$1.38M Sell
17,504
-807
-4% -$65.3K 0.12% 134
2016
Q3
$1.63M Sell
18,311
-10,529
-37% -$994K 0.15% 119
2016
Q2
$2.76M Buy
28,840
+2,478
+9% +$247K 0.27% 90
2016
Q1
$2.73M Buy
26,362
+9,615
+57% +$935K 0.28% 83
2015
Q4
$1.64M Buy
16,747
+5,190
+45% +$508K 0.17% 114
2015
Q3
$1.11M Buy
11,557
+1,039
+10% +$109K 0.13% 136
2015
Q2
$1.1M Buy
10,518
+604
+6% +$61.7K 0.11% 142
2015
Q1
$1.02M Buy
9,914
+7,463
+304% +$755K 0.11% 150
2014
Q4
$236K Buy
+2,451
New +$216K 0.03% 331
2014
Q3
Sell
-2,798
Closed -$211K 373
2014
Q2
$211K Hold
2,798
0.02% 358
2014
Q1
$210K Sell
2,798
-300
-10% -$21.2K 0.02% 328
2013
Q4
$222K Buy
+3,098
New +$199K 0.03% 306

Other funds holding CVS

Fulton Bank's CVS Position: Q2 2026 in Review

Fulton Bank reduced its CVS Health (CVS) stake by 3.1% in Q2 2026, selling an estimated $58.8K and leaving 20,807 shares worth $2.15M. The position accounts for 0.07% of the portfolio, ranked #203.

Fulton Bank first reported a position in CVS in Q4 2013 and has held it in 50 quarters since. The position peaked at $4.69M in Q4 2022. 432 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Fulton Bank held 20,807 shares of CVS Health worth $2.15M as of Q2 2026.
  • Fulton Bank sold 659 CVS Health shares in Q2 2026, an estimated $58.8K.
  • CVS Health made up 0.07% of Fulton Bank's portfolio in Q2 2026, its #203 holding.
  • Fulton Bank first reported a position in CVS Health in Q4 2013 and has held it in 50 quarters since.
  • Fulton Bank's CVS Health position peaked at $4.69M in Q4 2022.
  • 432 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Fulton Bank's 13F filing for Q2 2026, filed 9 Jul 2026.